000 01196 a2200325 4500
005 20250513192906.0
264 0 _c19991102
008 199911s 0 0 eng d
022 _a0085-5928
024 7 _a10.1080/003655299750025633
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLamers, C B
245 0 0 _aAzathioprine: an update on clinical efficacy and safety in inflammatory bowel disease.
_h[electronic resource]
260 _bScandinavian journal of gastroenterology. Supplement
_c1999
300 _a111-5 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAzathioprine
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aInflammatory Bowel Diseases
_xdrug therapy
650 0 4 _aRemission Induction
_xmethods
650 0 4 _aSafety
650 0 4 _aSecondary Prevention
650 0 4 _aTreatment Outcome
700 1 _aGriffioen, G
700 1 _avan Hogezand, R A
700 1 _aVeenendaal, R A
773 0 _tScandinavian journal of gastroenterology. Supplement
_gvol. 230
_gp. 111-5
856 4 0 _uhttps://doi.org/10.1080/003655299750025633
_zAvailable from publisher's website
999 _c10456642
_d10456642